137 related articles for article (PubMed ID: 18949270)
1. Quantification of cerebrospinal fluid ferritin as a biomarker for CNS malignant infiltration.
Almeida SM; Cunha DS; Yamada E; Doi EM; Ono M
Arq Neuropsiquiatr; 2008 Sep; 66(3B):720-4. PubMed ID: 18949270
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid cytological and biochemical characteristics in the presence of CNS neoplasia.
Almeida SM; Nanakanishi E; Conto AJ; Souza LP; Antonelli Filho D; Roda CD
Arq Neuropsiquiatr; 2007 Sep; 65(3B):802-9. PubMed ID: 17952285
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid ferritin--unspecific and unsuitable for disease monitoring.
Kolodziej MA; Proemmel P; Quint K; Strik HM
Neurol Neurochir Pol; 2014; 48(2):116-21. PubMed ID: 24821637
[TBL] [Abstract][Full Text] [Related]
4. Detection of Neoplasms by Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid.
Gu W; Rauschecker AM; Hsu E; Zorn KC; Sucu Y; Federman S; Gopez A; Arevalo S; Sample HA; Talevich E; Nguyen ED; Gottschall M; Nourbakhsh B; Gold CA; Cree BAC; Douglas VC; Richie MB; Shah MP; Josephson SA; Gelfand JM; Miller S; Wang L; Tihan T; DeRisi JL; Chiu CY; Wilson MR
JAMA Neurol; 2021 Nov; 78(11):1355-1366. PubMed ID: 34515766
[TBL] [Abstract][Full Text] [Related]
5. Pseudocholinesterase activity in cerebrospinal fluid as a biomarker of solid central nervous system tumors in children.
Mikecin L; Krizmaric M; Stepan Giljevic J; Gjurasin M; Kern J; Lenicek Krleza J; Popovic L
Croat Med J; 2013 Oct; 54(5):429-35. PubMed ID: 24170721
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma.
Strehlow F; Bauer S; Martus P; Weller M; Roth P; Schlegel U; Seidel S; Scheibenbogen C; Korfel A; Kreher S
J Neurooncol; 2016 Aug; 129(1):165-71. PubMed ID: 27294357
[TBL] [Abstract][Full Text] [Related]
7. [Ferritin in the cerebrospinal fluid as an early indicator of neuromeningeal involvement in patients with malignant lymphoma].
Aviles A; Gómez R; Salas J
Gac Med Mex; 1991; 127(3):249-52. PubMed ID: 1800218
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid ferritin in malignant CNS involvement.
Zandman-Goddard G; Matzner Y; Konijn AM; Hershko C
Cancer; 1986 Sep; 58(6):1346-9. PubMed ID: 3742459
[TBL] [Abstract][Full Text] [Related]
9. Beta-2-microglobulin and ferritin in cerebrospinal fluid for evaluation of patients with meningitis of different etiologies.
Takahashi S; Oki J; Miyamoto A; Moriyama T; Asano A; Inyaku F; Okuno A
Brain Dev; 1999 Apr; 21(3):192-9. PubMed ID: 10372906
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid ferritin in patients with leukaemia and malignant lymphoma.
Milman N; Vig L; Pedersen NS; Olsen TS
Scand J Haematol; 1985 Aug; 35(2):132-6. PubMed ID: 3863234
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Value of CRP, Procalcitonin, and Ferritin Levels in Cerebrospinal Fluid of Children with Meningitis.
Shokrollahi MR; Shabanzadeh K; Noorbakhsh S; Tabatabaei A; Movahedi Z; Shamshiri AR
Cent Nerv Syst Agents Med Chem; 2018 Jan; 18(1):58-62. PubMed ID: 26931764
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid biomarkers of malignancies located in the central nervous system.
Verheul C; Kleijn A; Lamfers MLM
Handb Clin Neurol; 2017; 146():139-169. PubMed ID: 29110768
[TBL] [Abstract][Full Text] [Related]
13. Concentrations of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3), IGF, and IGFBP-3 protease activity in cerebrospinal fluid of children with leukemia, central nervous system tumor, or meningitis.
Müller HL; Oh Y; Gargosky SE; Lehrnbecher T; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Nov; 77(5):1113-9. PubMed ID: 7521338
[TBL] [Abstract][Full Text] [Related]
14. The potential of cerebrospinal fluid-based liquid biopsy approaches in CNS tumors.
Mattox AK; Yan H; Bettegowda C
Neuro Oncol; 2019 Dec; 21(12):1509-1518. PubMed ID: 31595305
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of CSF soluble CD27 for primary central nervous system lymphoma in immunocompetent patients.
Murase S; Saio M; Andoh H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Takami T
Neurol Res; 2000 Jul; 22(5):434-42. PubMed ID: 10935213
[TBL] [Abstract][Full Text] [Related]
16. The relationship between cerebrospinal fluid osteopontin level and central nervous system involvement in childhood acute leukemia.
Incesoy-Özdemir S; Sahin G; Bozkurt C; Oren AC; Balkaya E; Ertem U
Turk J Pediatr; 2013; 55(1):42-9. PubMed ID: 23692831
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid beta-2-microglobulin in adult patients with acute leukemia or lymphoma: a useful marker in early diagnosis and monitoring of CNS-involvement.
Hansen PB; Kjeldsen L; Dalhoff K; Olesen B
Acta Neurol Scand; 1992 Mar; 85(3):224-7. PubMed ID: 1575009
[TBL] [Abstract][Full Text] [Related]
18. The CSF IL-10 concentration is an effective diagnostic marker in immunocompetent primary CNS lymphoma and a potential prognostic biomarker in treatment-responsive patients.
Nguyen-Them L; Costopoulos M; Tanguy ML; Houillier C; Choquet S; Benanni H; Elias-Shamieh R; Armand M; Faivre G; Glaisner S; Malak S; Vargaftig J; Hoang-Xuan K; Ahle G; Touitou V; Cassoux N; Davi F; Merle-Béral H; Le Garff-Tavernier M; Soussain C;
Eur J Cancer; 2016 Jul; 61():69-76. PubMed ID: 27156226
[TBL] [Abstract][Full Text] [Related]
19. Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies.
Kersten MJ; Evers LM; Dellemijn PL; van den Berg H; Portegies P; Hintzen RQ; van Lier RA; von dem Borne AE; van Oers RH
Blood; 1996 Mar; 87(5):1985-9. PubMed ID: 8634448
[TBL] [Abstract][Full Text] [Related]
20. Significance of elevated levels of soluble factors in the cerebrospinal fluid in patients with adult T-cell leukemia.
Uozumi K; Ishitsuka K; Ohno N; Nakahara K; Utsunomiya A; Hanada S; Arima T
Leuk Lymphoma; 1995 Nov; 19(5-6):437-45. PubMed ID: 8590844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
